Emcure Pharmaceuticals Limited CC-Jun25.pdf · 2025-08-07
Thanks for the opportunity. Joined which a bit late so I'm not sure if you have already addressed. But just wanted to understand on th e gross margin front quarter -over-quarter, where it's a business composition in terms of geography has not changed much, but we've seen good improvement in the gross margin. If you could just elaborate on that first?
And therapy -wise as far as the India market is concerned, of course, there's secondary data available, b ut if you could throw some light in terms of these therapies, we have sort of performed better than the industry and where we have dragged?